← Leaderboards
Bentley M. Shuster
Columbia Univ New York Morningside
$150,669
Attributed
$150,669
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $64.6K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$150,669 · 1
By mechanism
F32$150,669 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia Univ New York Morningside
Same institution · by research overlap
- Michael P Sheetz$18,554,178
- Tal Danino$10,808,082
- Tetsuhiro Harimoto$497,051
- Nicholas Arpaia$10,668,029
- Zakary Singer$191,090
Others in their field
Other Emerging Leaders on “Aerobic”
- Susan M Landau · University Of California Berkeley$47,252,026
- Jessica Scott · Sloan-Kettering Inst Can Research$10,593,887
- Alexander Egbe · Mayo Clinic Rochester$7,415,297
- Andrei G. Vlassenko · Washington University$6,750,146
- Pierce Boyne · University Of Cincinnati$5,412,610
- Mark Andrew Sarzynski · Beth Israel Deaconess Medical Center$4,936,886
Research focus
AerobicAffectiveAnimal ModelAnti-CancerAntimicrobialAntineoplastic AgentsBacillusBacillus LicheniformisBacillus MegateriumBacillus SubtilisBacteriaBiologicalBiological Response Modifier TherapyBiomedical EngineeringCancer CellCancer TherapyCause Of DeathCellsCoculture TechniquesColon CarcinomaColorectalCommunitiesCt263-Dimensional
Grant awards (3)
Optimizing Gram-positive bacteria as a candidate for targeted anti-tumor therapy$29,155
F32 · FY2022 · CA · contact PI
Optimizing Gram-positive bacteria as a candidate for targeted anti-tumor therapy$56,960
F32 · FY2021 · CA · contact PI
Optimizing Gram-positive bacteria as a candidate for targeted anti-tumor therapy$64,554
F32 · FY2020 · CA · contact PI